MarketCapExport financials
Annovis Bio (ANVS)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Annovis Bio Balance Sheet 2025-2011 | ANVS
Brief overview of Annovis Bio's financial position
The comparison uses five available annual reports from the 2021–2025 interval.
Across five reporting periods, assets decreased -54.2%, from $46 million to $21.1 million, producing a negative trend.
Funding shifted toward liabilities: they gained +180.8%, compared with -54.2% for assets.
Equity funds 79.9% of assets versus 96.7% initially. This creates a conservative balance sheet structure.
Cash represents 92.7% of assets versus 99.3% initially, showing how the immediate liquidity reserve changed.
Retained earnings are negative at -$163.7 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.
Overall picture
Annovis Bio's financial structure calls for caution. Stronger equity, lower debt or restored liquidity would be needed to improve it.
Annual Balance Sheet Annovis Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | - | - | -8.07 M | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
3.64 M | 3.88 M | 4.28 M | 7.7 M | 1.51 M | 578 K | - | - | - | - | - | - | - | - | - |
Total Liabilities |
4.23 M | 4.62 M | 18 M | 7.7 M | 1.51 M | 578 K | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-164 M | -135 M | -110 M | -54.1 M | -28.7 M | -14.2 M | - | - | - | - | - | - | - | - | - |
Total Assets |
21.1 M | 13.9 M | 10.2 M | 36 M | 46 M | 8.12 M | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
19.5 M | 10.6 M | 5.75 M | 28.4 M | 45.7 M | 8.07 M | 1.86 K | - | - | - | - | - | - | - | - |
Book Value |
16.9 M | 9.31 M | -7.75 M | 28.3 M | 44.5 M | 7.54 M | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
16.9 M | 9.31 M | -7.75 M | 28.3 M | 44.5 M | 7.54 M | -8.58 M | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet Annovis Bio
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 606 K | 606 K | 606 K | 606 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
13.1 M | 4.03 M | 3.12 M | 2.68 M | 4.62 M | 7.3 M | 6.8 M | 11.2 M | 18 M | 3.56 M | 2.07 M | 5.41 M | 7.7 M | 2.53 M | 1.3 M | 1.4 M | 1.51 M | 1.12 M | 884 K | 1.6 M | 578 K | 578 K | 578 K | 578 K | 2.62 M | 2.62 M | 2.62 M | 2.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-181 M | -154 M | -147 M | -140 M | -135 M | -129 M | -116 M | -111 M | -110 M | -88 M | -73.3 M | -63.8 M | -54.1 M | -46.3 M | -39.9 M | -34 M | -28.7 M | -22.8 M | -20 M | -17.4 M | -14.2 M | -14.2 M | -14.2 M | -14.2 M | -8.78 M | -8.78 M | -8.78 M | -8.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
16.2 M | 17.2 M | 21.5 M | 26.7 M | 13.9 M | 14.4 M | 5.05 M | 7.81 M | 10.2 M | 10.2 M | 22.8 M | 25.5 M | 36 M | 37.1 M | 40 M | 44.1 M | 46 M | 47.7 M | 49.5 M | 5.96 M | 8.12 M | 8.12 M | 8.12 M | 8.12 M | 1.12 M | 1.12 M | 1.12 M | 1.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
14.2 M | 15.3 M | 17.1 M | 22.2 M | 10.6 M | 12.6 M | 4 M | 3.14 M | 5.75 M | 6.35 M | 15.7 M | 16.8 M | 28.4 M | 32 M | 36 M | 42.7 M | 45.7 M | 47.5 M | 49.2 M | 5.6 M | 8.07 M | 8.07 M | 8.07 M | 8.07 M | 1.86 K | 1.86 K | 1.86 K | 1.86 K | 35.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
3.13 M | 13.2 M | 18.3 M | 24.1 M | 9.31 M | 7.06 M | -1.75 M | -3.35 M | -7.75 M | 6.66 M | 20.7 M | 20.1 M | 28.3 M | 34.6 M | 38.7 M | 42.7 M | 44.5 M | 46.5 M | 48.6 M | 4.37 M | 7.54 M | 7.54 M | 7.54 M | 7.54 M | -1.5 M | -1.5 M | -1.5 M | -1.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
3.13 M | 13.2 M | 18.3 M | 24.1 M | 9.31 M | 7.06 M | -1.75 M | -3.35 M | -7.75 M | 6.66 M | 20.7 M | 20.1 M | 28.3 M | 34.6 M | 38.7 M | 42.7 M | 44.5 M | 46.5 M | 48.6 M | 4.37 M | 7.54 M | 7.54 M | 7.54 M | 7.54 M | -8.58 M | -8.58 M | -8.58 M | -8.58 M | -7.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of Annovis Bio, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Canada
USA
Russia
Niderland
Israel
Spain
Germany
Australia
Britain
